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Abstract
A considerable number of epidemiological investigations and intervention studies have supported an association between the intake of
flavanol- and proanthocyanidin-containing foods and a decreased risk of metabolic diseases. Nonetheless, less is know about the capacity
of tissues to accumulate flavanols and/or their metabolites. The main objective of the present study was to determine (n 20) plasma bio-
availability and disposition in the liver, muscle, brown adipose tissue (BAT) and white adipose tissues (mesenteric and perirenal) in rats
after a long-term consumption of three doses of grape seed phenolic extract (5, 25 and 50 mg/kg body weight) for 21 d in order to deter-
mine whether there is a dose–response relationship. Glucuronidated conjugates (total glucuronidated conjugates: C5 mg/kg 1·9; C25 mg/kg
6·4; C50 mg/kg 27·7mmol/l plasma) followed by methyl glucuronidated conjugates (total methyl glucuronidated conjugates: C5 mg/kg 1·98;
C25 mg/kg 4·48; C50 mg/kg 12·5mmol/l plasma) were the main flavanol metabolites quantified in plasma, also detecting a dimer in its free
form (C25 mg/kg 0·74; C50 mg/kg 0·79mmol/l plasma). Each of the studied organs has a particular behaviour of accumulation and response
to the assayed grape seed extract doses, with an exponential bioavailability–dose relationship in BAT, in which flavanols could play an
important role in the reduction or prevention of obesity, modulating the functionality of that tissue.
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Flavan-3-ol and proanthocyanidins are the most abundant
flavonoid subgroups in the human diet(1), with a total
flavonoid intake of 313 mg/d for the Spanish population
(proanthocyanidins: 189 mg/d; flavonoids without proantho-
cyanidins: 124 mg/d), where proanthocyanidins represent
60 % of the total phenolic intake(2). These compounds are
mainly found in apples, legumes, grapes, nuts, red wine,
tea and cocoa(3). Epidemiological research and intervention
studies have supported an association between the intake
of foods containing flavanol and proanthocyanidin and
a decreased risk of diseases, in particular CVD(4–6) and
cancer(7). Moreover, the consumption of flavanol- and pro-
anthocyanidin-rich foods improves dyslipidaemia(8,9), insulin
sensitivity(10) and obesity(11) in humans.
Grape seed proanthocyanidin extract (GSPE) improves the
atherosclerotic risk index and reduces postprandial triacylgly-
cerolaemia, in both healthy(12,13) and dyslipidaemic rats(14).
Moreover, GSPE improves glycaemia in rats with altered
glucose homeostasis(15,16). In addition, GSPE modulates
mitochondrial function, increasing their oxidative capacity in
the muscle, white adipose tissue (WAT) and brown adipose
tissue (BAT) of rats(17). The action of the bioactive compounds
contained in GSPE could be linked to the modulation of
signalling pathways, as occurs with the activation of the
insulin receptor and key targets of insulin signalling path-
ways(18). Moreover, the hypolipidaemic action of GSPE is
mediated by the nuclear receptors farnesoid-X-receptor and
small heterodimer partner, a signalling pathway leading to
lowered lipogenesis and secretion of VLDL in the liver, as
demonstrated in previous experiments(19,20).
Over recent years, great effort has been made to
determine flavanol and proanthocyanidin bioavailability
with a low grade of polymerisation, confirming dimer and
trimer absorption(21–24). Furthermore, plasma kinetics of
parental molecules and metabolites have been defined(25,26).
However, less is known about the capacity of organs to
accumulate flavanols and/or their metabolites. Previous exper-
iments have demonstrated the tissue distribution of flavanol
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metabolites practically throughout the body, even crossing
the blood–brain barrier, after an acute intake of a flavanol-
rich extract(27), and a similar profile of tissue disposition was
detected after an acute intake of a dietary dose of flavanols
and proanthocyanidins with a low grade of polymerisation,
using cocoa cream as a source of polyphenols(28). Flavanol
metabolites and phenolic acids have been detected at
nanomolar levels in tissues, such as the heart, lung and
liver. However, information derived from an acute intake
experiment is not sufficient to evaluate correctly the tissue
distribution of flavanols and proanthocyanidins with a low
grade of polymerisation and/or their metabolites in tissues.
To gain insight into the molecular mechanisms used by
flavonoids to modify lipid, glucose and energy metabolism,
it is essential to determine which flavanol and/or metabolite
reaches and accumulates in the liver and adipose tissues. As
mentioned above, the concentrations of flavonoid metabolites
in organs have been measured with acute and high doses of
flavanols(27,28). Thus, the aim of the present study was to
determine flavanol metabolites in rat liver, muscle and adipose
tissues after a long-term consumption of lower doses of GSPE
than previously studied, this being a situation closer to that
of the real human consumption of proanthocyanidins.
The experiment was performed with three doses of GSPE
(5, 25 or 50 mg/kg body weight) for 21 d in order to determine
whether there is a dose–response metabolite distribution in
the liver, muscle, WAT (mesenteric and perirenal) and BAT.
Materials and methods
Chemicals and reagents
GSPE was kindly provided by Les De´rives Re´siniques et Terpe´-
niques. This proanthocyanidin extract contained monomers
(58mmol catechin/g extract, 52mmol epicatechin/g extract,
5·5mmol epigallocatechin/g extract, 89mmol epicatechin gal-
late/g extract, 1·4mmol epigallocatechin gallate/g extract),
dimers (250mmol/g extract), trimers (1568mmol/g extract),
tetramers (8·8mmol/g extract), pentamers (0·73mmol/g
extract) and hexamers (0·38mmol/g extract).
The internal standard catechol, and the standards of
(2)-epicatechin, (þ)-catechin, (2)-epigallocatechin and
(2)-epigallocatechin-3-O-gallate were purchased from Sigma
Aldrich and proanthocyanidin dimer B2 (epicatechin-(4b-8)-
epicatechin) from Fluka Company. Acetonitrile (HPLC
grade), methanol (HPLC grade), acetone (HPLC grade) and
glacial acetic acid ($99·8 %) were of analytical grade (Scharlab).
Ortho-phosphoric acid (85 %) was purchased from MontPlet &
Esteban S. A. Formic acid and L-(þ)-ascorbic acid (reagent
grade) were all provided by Scharlau Chemie. Ultrapure water
was obtained from a Milli-Q water purification system (Millipore
Corporation).
Treatment of animals and plasma and tissue collection
A total of twenty male Wistar rats (5–6 weeks) weighing
150–175 g were purchased from Charles River. The animals
were housed in animal quarters at 228C with a 12 h light–12 h
dark cycle (lights on from 08.00 to 20.00 hours) and were fed
ad libitum with a standard chow diet (Panlab) and tap water.
After 1 week of adaptation, the animals were trained to lick con-
densed milk (1 ml), which was used as a vehicle for administer-
ing GSPE, for an additional week. After this period, the animals
were randomly divided into four groups (n 5 each group),
including the control group. Each group was treated with 5,
25 or 50 mg GSPE/kg body weight per d dispersed in condensed
milk. The control group was treated with condensed milk. GSPE
was administered every day at 09.00 hours for 21 d. On day 21,
5 h after the GSPE treatment, rats were anaesthetised with keta-
mine/xylazine and killed by exsanguination from the abdomi-
nal aorta using syringes, with heparin as the anticoagulant.
Plasma was obtained by centrifugation and stored at 2808C
until analysis. Liver, muscle, BAT and mesenteric and perirenal
WAT were excised and frozen immediately in liquid N2 and
stored at 2808C until the analysis of phenolic metabolites. All
experimental procedures were performed according to the cur-
rent national and institutional guidelines for animal care and in
place at Universitat Rovira i Virgili (Spain). The Animal Ethics
Committee of the Universitat Rovira i Virgili approved all the
procedures.
Extraction of flavanols and proanthocyanidins with a low
grade of polymerisation from plasma and tissues
The method used to extract flavanols and proanthocyanidins
with a low grade of polymerisation and their metabolites from
plasma and tissues was based on the methodologies described
in our previous papers(29,30). In order to clean up the biological
matrix and to preconcentrate the phenolic compounds, plasma
samples were pretreated by microelution solid-phase extrac-
tion, and rat tissue samples were pretreated by a combination
of liquid–solid extraction and microelution solid-phase extrac-
tion. Briefly, the extraction was done with 60 mg of freeze-dried
tissue to which 50ml of ascorbic acid (1 %), 50ml of catechol
(20 mg/l, dissolved in 4 % phosphoric acid) as an internal stan-
dard and 100ml of phosphoric acid (4 %) were added. The
sample was extracted four times with 400ml of 4 % water–
methanol–phosphoric acid (94:4:1, by vol.). Then, 400ml of
the extraction solution were added to each extraction. The
sample was sonicated during 30 s, maintained in a freeze
water-bath to avoid heating and then centrifuged for 15 min at
14 000 rpm, 208C. The supernatants were collected, and then
the extracts were treated by microelution solid-phase extraction
before the chromatographic analysis of flavanols and proantho-
cyanidins with a low grade of polymerisation and their metab-
olites. OASIS HLB mElution Plates (30mm; Waters) were used.
Briefly, these were conditioned sequentially with 250ml of
methanol and 250ml of 0·2 % acetic acid. Then, 350ml of 4 %
phosphoric acid were added to 350ml of the tissue extract or
plasma, and then this mixture was loaded onto the plate. The
loaded plates were washed with 200ml of Milli-Q water and
200ml of 0·2 % acetic acid. Then, the retained molecules (flava-
nols and proanthocyanidins with a low grade of polymerisation
and their metabolites) were eluted with 2 £ 50ml of acetone–
Milli-Q water–acetic acid solution (70:29·5:0·5, by vol.). The
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eluted solution was directly injected into the chromatographic
system, and the sample volume was 2·5ml.
Analysis of flavanols and proanthocyanidins with a
low grade of polymerisation and their metabolites by
ultra-performance liquid chromatography-electrospray
ionisation-MS/MS
Flavanols and proanthocyanidins with a low grade of polym-
erisation were analysed by Acquity ultra-performance-liquid
chromatography from Waters and tandem MS, as reported in
our previous studies(30,31). Briefly, the column was Acquity
high strength silica T3 (100 mm £ 2·1 mm inner diameter,
1·8mm particle size) with 100 % silica particles (Waters). The
mobile phase was 0·2 % acetic acid as eluent A, and aceto-
nitrile as eluent B. The flow rate was 0·4 ml/min and the
analysis time 12·5 min. Tandem MS analyses were carried out
on a triple quadrupole detector mass spectrometer (Waters)
equipped with a Z-spray electrospray interface. The ionisation
technique was electrospray ionisation. Flavanols and pro-
anthocyanidins with a low grade of polymerisation and their
metabolites were analysed in the negative ion mode and
data were acquired through selected reaction monitoring.
For each analyte, two selected reaction monitoring transitions
were studied, the most sensitive transition being selected for
quantification and a second one for confirmation purposes
(see the Supplementary material, available online). The dwell
time established for each transition was 30 ms. Data acquisition
was carried out with MassLynx v 4.1 software (Waters). Consid-
ering the ultra-performance liquid chromatography elution
order of catechin and epicatechin and the elution order of
their metabolites, together with the MS fragmentation pattern,
the earlier eluting peaks were assigned to catechin metabolites,
while the peaks eluting later were assigned to epicatechin
metabolites. Catechin and epicatechin metabolites were
tentatively quantified using the calibration curve of (þ)-cate-
chin and (2)-epicatechin, respectively. Dimers, which
corresponded to the sum of four peaks of the extracted ion
chromatogram at the transition of 577 . 289(31), were quanti-
fied using the calibration curve of the commercial standard
dimer B2 (epicatechin-(4b-8)-epicatechin). In the present
study, quality parameters of the method, such as the limit of
detection (LOD) and the limit of quantification (LOQ), are
reported. For the determination of catechin in the liver and adi-
pose tissue, LOD were 0·4 and 1·8 nmol/g, and LOQ were 1·0
and 6·1 nmol/g, respectively. On the other hand, for the deter-
mination of epicatechin in the liver and adipose tissue, LOD
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Fig. 1. Flavanol metabolites and procyanidins with a low grade of polymerisation concentrations, expressed as mmol/l, quantified in plasma after a 21 d long-term
intake of grape seed proanthocyanidin extract (GSPE) at different doses (5, 25 and 50mg/kg body weight). a,b,cMean values with unlike letters within the same
metabolite concentration were significantly different between the GSPE doses (P,0·05). *Mean values were significantly different between the tested dose and
the control group of rats (without GSPE intake) (P,0·05). ND, not detected; NQ, not quantified.
Flavanols, adipose tissues, muscle and liver 1413
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https://doi.org/10.1017/S0007114513000706
Downloaded from https://www.cambridge.org/core. Universitat de Lleida, on 05 Oct 2018 at 07:23:57, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
were 0·6 and 1·6 nmol/g, and LOQ were 1·0 and 4·5 nmol/g,
respectively(29). As a consequence, in the present study, when
the concentration of the generated metabolite was lower than
the LOD, it was considered not detected, and when its concen-
tration was below the LOQ, it was considered not quantified.
Statistical analysis
Data are expressed as means and standard deviations. Statisti-
cal analysis was performed using two-way ANOVA followed
by the Tukey–Kramer honestly significant difference multiple
comparison test. A P value ,0·05 was considered as
significant. All statistical analyses were performed using JMP
software (version 8.0.2; SAS Institute, Inc.).
Results
After a regular 21 d consumption of GSPE at different doses
(5, 25 and 50 mg/kg body weight), several flavanol metab-
olites were identified in the plasma (Fig. 1). Glucuronidated
conjugates followed by methyl glucuronidated conjugates
were the main flavanol metabolites quantified in the plasma,
and methyl catechin sulphate was quantified at lower concen-
trations. In contrast, methyl epicatechin sulphate was only
quantified at the trace level (0·02mmol/l plasma) after the
higher tested long-term dose (50 mg/kg). Additionally, dimer
was also quantified in plasma samples. Significant differences
(P,0·05) were observed for flavanol plasma concentrations
between the doses. For plasma glucuronidated forms,
significant differences were only detected with the highest
tested dose (CCat_50 mg/kg 21mmol/l plasma and CEpi_50 mg/kg
11mmol/l for catechin glucuronide (P,0·001) and epicatechin
glucuronide (P,0·001), respectively) compared with the
lowest doses, although glucuronidated forms of catechin and
epicatechin were quantified in the plasma 21 d after all the
tested long-term intakes. A similar behaviour, with significant
differences at 50 mg/kg, was observed for methyl epicatechin
glucuronide. On the other hand, dimer was quantified at simi-
lar concentrations (approximately 0·75mmol/l plasma) after
the 25 and 50 mg/kg of long-term doses. However, dimer
was not detected after the 5 mg/kg dose. Methyl catechin
sulphate was quantified at a lower concentration in the
plasma than glucuronide (P,0·001) and methyl glucuronide
(P,0·001) conjugates after the 25 and 50 mg/kg long-term
doses, and catechin sulphate was only quantified with the
50 mg/kg dose.
Related to the distribution of flavanol metabolites in tissues,
as shown in Fig. 2, the liver and muscle showed a direct
relationship between the accumulation and the administered
doses of GSPE for all the quantified flavanol metabolites. No
flavanol metabolites were quantified in the liver after the
lower long-term dose (5 mg/kg). In addition, high concen-
tration levels were detected at 25 and 50 mg/kg. Methyl glu-
curonide conjugates were the most abundant flavanol
metabolites quantified in the liver. Glucuronidated conjugates
were the most abundant metabolites detected in the muscle,
followed by methyl glucuronidated conjugates. As regards
the adipose tissues (Fig. 3), a significant dose-dependent
accumulation was observed in BAT for the total flavanol
metabolites. Significant differences were detected for all the
quantified metabolites 21 d after the 50 mg/kg dose compared
with the lower doses (P,0·001). Glucuronidated and methyl
glucuronidated conjugates of catechin and epicatechin were
determined in BAT. On the other hand, in the mesenteric
and perirenal adipose tissues, no dose-dependent accumu-
lation was observed. Also glucuronidated and methyl glucuro-
nidated conjugates of catechin and epicatechin were
quantified in both adipose tissues. Nonetheless, with the
5 mg/kg dose, practically, no metabolites were detected and
significant differences for epicatechin and catechin glucuro-
nide were only detected in the brown and mesenteric adipose
tissues (P,0·05) between 25 and 50 mg/kg. It should be noted
that dimer was not detected in any of the studied tissues (data
not shown).
Table 1 allows the detection of significant differences
between the tissues for each metabolite differentiating
between the ingested doses of GSPE. For catechin glucuro-
nide, at the 5 mg/kg dose, muscle was the tissue with the
greatest accumulation. In contrast, tissue distribution was
more homogeneous at higher doses, with no significant differ-
ences between the muscle, BAT, mesenteric adipose tissue
and perirenal adipose tissue, except for the liver, in which
the concentration of metabolites remained low. The opposite
situation was observed for methyl catechin glucuronide that at
low dose (5 mg/kg) was not detected in any tissue. Neverthe-
less, with increasing doses, accumulation was concentrated in
the liver. Regarding methyl sulphated conjugates, tissue
deposition was very low. A low accumulation of metabolites
after the treatment with doses of GSPE at 25 and 50 mg/kg
was only observed in the liver. The epicatechin glucuroni-
dated conjugate was accumulated mainly in the mesenteric
adipose tissue during the 5 mg/kg dose. At 25 and 50 mg/kg,
accumulation was concentrated in the three adipose tissues
(brown, perirenal and mesenteric) with no significant differ-
ence between them. Methyl epicatechin glucuronide, at the
5 mg/kg dose, was only accumulated in BAT, showing a
value of concentration between the LOD (1·8 nmol/g tissue)
and the LOQ (6·1 nmol/g tissue) determined for epicatechin
in the adipose tissue(27). At a higher dose of GSPE (25mg/kg),
mesenteric and perirenal adipose tissues showed the highest
accumulations. In return, at 50 mg/kg of GSPE, liver, mesen-
teric and perirenal adipose tissues showed the highest concen-
tration. No phenolic metabolites were detected in plasma and
tissues in the control group of rats (data not shown).
Discussion
Liver, muscle and adipose tissues are crucial in the homeostasis
of TAG and glucose. Moreover, obesity depends on fat accumu-
lation in WAT and on energy wasted in BAT(32). Therefore,
in order to understand the role of flavanols in improving
hypertriacylglycerolaemia(13,14,33,34), hyperglycaemia(4,35–38)
and obesity(11), it is essential to know whether flavanols reach
these organs and which metabolites could be responsible for
their effects. The present study shows the plasma bioavailability
and tissue distribution of flavanol metabolites in the WAT
A. Serra et al.1414
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Fig. 3. Flavanol metabolites quantified in white adipose tissues (mesenteric (A) and perirenal (B)) and brown adipose tissues (C) after a 21 d long-term intake of
grape seed proanthocyanidin extract at different doses (5, 25 and 50mg/kg body weight). Values are means (nmol/g tissue), with standard deviations represented
by horizontal bars. a,b,cMean values with unlike letters within the same metabolite concentration were significantly different between the doses (P,0·05). ND, not
detected; NQ, not quantified.
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(mesenteric and perirenal), BAT, muscle and liver after a regular
21 d intake of GSPE. The results obtained show that each of the
organs studied has a specific pattern of metabolite accumulation
and response to the assayed GSPE doses.
The presence of several catechin and epicatechin meta-
bolites in the plasma reinforces the fact that procyanidins
are intensely metabolised by the small intestine and liver.
Plasma catechin conjugates are more abundant than epicatechin
conjugates, a fact directly related to the proportion of catechin
and epicatechin in GSPE (6·3 (SD 0·54)mmol/g of GSPE and
2·4 (SD 0·13)mmol/g of GSPE, respectively, data shown in a
previous work(21)). Glucuronidated conjugates, followed by
methyl glucuronidated conjugates, were the main flavanol
metabolites detected in the plasma, and this agrees with the
existing literature(27,39–42).
Previous studies have shown a high number of phase II metab-
olites in the liver after a long-term intake of catechin(43). By con-
trast, after an acute intake of a proanthocyanidin-rich extract,
these phenolic metabolites were not detected in the liver(27).
However, the results of the present study show that the sulphate
conjugates of catechin and epicatechin were only deposited in
the liver, showing a dose–response accumulation and indicating
Table 1. Flavanol metabolite concentrations in the rat liver, muscle, brown adipose tissue
and white adipose tissues (mesenteric and perirenal) after a 21 d chronic intake of grape
seed proanthocyanidin extract at different doses (5, 25 and 50mg/kg body weight), with n 5
for each dose
(Mean values (nmol/g tissues) and standard deviations)
Ingested dose
50mg/kg 25mg/kg 5mg/kg
Tissue Mean SD Mean SD Mean SD
Catechin glucuronide
Liver 4·2b 1·1 1·8c 0·07 ND
Muscle 28a 2·6 26a,b 3·5 15 1·4
Brown adipose tissue 44a 3·9 8·7b,c 1·6 NQ
Mesenteric adipose tissue 31a 4·9 15b,c 0·75 ND
Perirenal adipose tissue 41a 4·2 39a 1·3 ND
P ,0·0001 ,0·0001
Methyl catechin glucuronide
Liver 78a 15·2 47a 13 ND
Muscle 15b 1·2 8·9b 4·4 ND
Brown adipose tissue 29b 1·7 9·1b 1·9 ND
Mesenteric adipose tissue 16b 3·2 17a,b 4·3 ND
Perirenal adipose tissue 34b 2·7 37a,b 3·2 ND
P ,0·0001 0·0048 –
Methyl catechin sulphate
Liver 6·0 0·98 1·8 1·6 ND
Muscle ND ND ND
Brown adipose tissue ND ND ND
Mesenteric adipose tissue ND ND ND
Perirenal adipose tissue ND ND ND
P ,0·0001 0·0507 –
Epicatechin glucuronide
Liver 15b 2·1 5·6c 1·3 ND
Muscle 26b 2·4 9·9b,c 1·7 2·0b 0·1
Brown adipose tissue 57a 3·1 17b 2·2 ND
Mesenteric adipose tissue 56a 2·9 48a 1·7 8·9a 2·3
Perirenal adipose tissue 37a,b 3·8 40a 4·2 ND
P ,0·0001 ,0·0001 ,0·0001
Methyl epicatechin glucuronide
Liver 51a 11 17b 4·9 ND
Muscle 4·3c 0·7 3·4c 0·3 ND
Brown adipose tissue 26b 2·4 NQ NQ
Mesenteric adipose tissue 46a 0·69 42a 0·34 ND
Perirenal adipose tissue 35a,b 2·7 36a 3·9 ND
P ,0·0001 ,0·0001 –
Methyl epicatechin sulphate
Liver 6·5 1·2 2·9 0·15 ND
Muscle ND ND ND
Brown adipose tissue ND ND ND
Mesenteric adipose tissue ND ND ND
Perirenal adipose tissue ND ND ND
P –
ND, not detected; NQ, not quantified.
a,b,cMean values within a column with unlike superscript letters were significantly different between the
tissues.
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sulphation capacity of rat hepatocytes. Nonetheless, these
sulphated conjugates were not detected in the liver after the treat-
ment with 5mg GSPE/kg body weight. Moreover, their presence
in the plasma at low concentrations could reflect the possible
sulphotransferase activity of the platelets, as was observed by
Anderson et al.(44) who incubated hydroxytyrosol, a phenyl alco-
hol typical of virgin olive oil, in whole blood.
Glucuronide conjugates were detected in all the organs
studied, but their distribution and concentration may depend
on methylation. Non-methylated glucuronide derivatives
were mainly accumulated in BAT and in the two white adipose
depots studied, mesenteric and perirenal. On the other hand,
methyl catechin glucuronide was accumulated mainly in the
liver, whereas methyl epicatechin glucuronide was accumu-
lated mainly in BAT and WAT. It is important to highlight
that the accumulation of glucuronide derivatives in white
adipose depots was not dose responsive. In both the WAT
studied (perirenal and mesenteric), the levels of glucuronide
derivatives were similar, at 25 and 50 mg of GSPE/kg body
weight. This could be related to the storage limit in white
adipose cells. However, this might be more related to the
saturation of uridine 50-diphospho-glucuronosyltransferase
enzymes responsible for the formation of glucuronidated
conjugates. These enzymes are located in the endoplasmic
reticulum in many tissues and catalyse the transfer of glucuro-
nic acid from uridine 50-diphospho-glucuronic acid to steroids,
bile acids, polyphenols and xenobiotics(45). Moreover, the
concentration of some of these metabolites was even higher
than that in the other tissues studied. Taken together, it can
be suggested that visceral WAT could be a store for flavanol
metabolites in the body. Nonetheless, further studies are
needed to understand whether flavanols accumulate in adipo-
cytes or other cell types in the adipose tissue.
BAT could represent a very important target for flavanol
metabolites, due to, for example, their improvement in
mitochondrial function related to energy homeostasis of
the BAT(17). This tissue is the only tissue with detectable
levels of all the glucuronidated derivatives at the lowest
GSPE dose (5 mg/kg body weight). Moreover, BAT showed a
dose–response in the concentration of all the conjugate
metabolites of catechin and epicatechin. Moreover, some of
these metabolites reached high concentrations, probably
related to the high irrigation of this type of adipose tissue by
blood vessels(46). These results, together with the possible
enhancement of thermogenic capacity and the improvement
in mitochondrial function exerted by a long-term supplemen-
tation of proanthocyanidins in BAT(17,47), it can be suggested
that proanthocyanidins may play an important role in redu-
cing or preventing obesity by modulating the functionality of
BAT at low doses.
The dose-dependent disposition of phase II metabolites
of procyanidins detected in the muscle may also be related
to an improvement in mitochondrial function in skeletal
muscle detected in a previous experiment(47), suggesting an
improvement in the activity of enzymes involved in the
oxidation and metabolism of pyruvate, and a shift in priority
to glycosidic metabolism rather than lipid metabolism.
Conclusions
In the present study, after a long-term intake of flavanol-rich
extract at different doses, plasma bioavailability, distribution
and accumulation of flavanols and their metabolites in the
adipose tissues, muscle and liver were studied. Each of the
studied organs has a specific behaviour of accumulation and
response to the assayed GSPE doses, with a clear dose–
response in BAT, in which flavanols could play an important
role in reducing or preventing obesity by modulating the func-
tionality of that tissue. The results of the present experiment
could be useful for future in vitro research with adipose cell
culture giving information about the physiological concen-
trations reached in specific adipose tissues after a long-term
intake of flavanols.
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